BRPI0415366A - long-acting composition to control parasites internal and external to animals, and use of the same - Google Patents
long-acting composition to control parasites internal and external to animals, and use of the sameInfo
- Publication number
- BRPI0415366A BRPI0415366A BRPI0415366-9A BRPI0415366A BRPI0415366A BR PI0415366 A BRPI0415366 A BR PI0415366A BR PI0415366 A BRPI0415366 A BR PI0415366A BR PI0415366 A BRPI0415366 A BR PI0415366A
- Authority
- BR
- Brazil
- Prior art keywords
- external
- animals
- internal
- long
- same
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicinal Preparation (AREA)
Abstract
"COMPOSIçãO DE EFEITO PROLONGADO PARA CONTROLAR PARASITAS INTERNOS E EXTERNOS AOS ANIMAIS, E, USO DA MESMA". Uma composição de efeito prolongado para controlar parasitas internos e externos aos animais, que compreende, em um veículo de liberação lenta, uma combinação de ivermectina e abamectina, em que a percentagem total p/v de ivermectina e abamectina iguala ou excede 3% p/v e a concentração de ivermectina é mais elevada do que a concentração de abamectina."Prolonged Effect Composition to Control Internal and External Parasites to Animals, and Use of the Same". A long-acting composition for controlling internal and external animal parasites, comprising in a slow release vehicle a combination of ivermectin and abamectin, wherein the total w / v percentage of ivermectin and abamectin equals or exceeds 3% w / w. The ivermectin concentration is higher than the abamectin concentration.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03078280 | 2003-10-17 | ||
PCT/EP2004/052554 WO2005037294A1 (en) | 2003-10-17 | 2004-10-15 | Compositions for controlling parasites comprising a combination of abamectin and ivermectin |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0415366A true BRPI0415366A (en) | 2006-12-12 |
Family
ID=34442985
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0415366-9A BRPI0415366A (en) | 2003-10-17 | 2004-10-15 | long-acting composition to control parasites internal and external to animals, and use of the same |
Country Status (7)
Country | Link |
---|---|
CN (1) | CN1867341B (en) |
AU (1) | AU2004281551B2 (en) |
BR (1) | BRPI0415366A (en) |
NZ (1) | NZ546340A (en) |
TR (1) | TR200601608T1 (en) |
WO (1) | WO2005037294A1 (en) |
ZA (1) | ZA200603931B (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1849363A1 (en) * | 2006-03-09 | 2007-10-31 | Cheminova A/S | Synergistic combination of glutamate- and GABA-gated chloride agonist pesticide and at least one of Vitamin E or Niacin |
WO2010008891A2 (en) * | 2008-06-24 | 2010-01-21 | Merial Limited | Anthelminthic formulations |
KR20140136005A (en) | 2012-03-13 | 2014-11-27 | 바이엘 뉴질랜드 리미티드 | Long acting compositions |
CN104430394A (en) * | 2014-10-20 | 2015-03-25 | 广西大学 | Preparation method of ivermectin/emamectin benzoate compound microcapsule suspension |
CN109329077A (en) * | 2018-09-27 | 2019-02-15 | 江苏省协同医药生物工程有限责任公司 | A kind of anti parasitic experimental animal padding and preparation method thereof |
CN110721152B (en) * | 2018-12-29 | 2022-01-14 | 瑞普(天津)生物药业有限公司 | Sustained-release composition for treating animal skin parasite and fungus infection |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8813353D0 (en) * | 1988-06-06 | 1988-07-13 | Ici Plc | Therapeutic product |
CN1375293A (en) * | 2001-03-16 | 2002-10-23 | 王玉万 | Mixed vermifuge injection containing iodo-ether salicylamine |
BR0104761A (en) * | 2001-08-08 | 2003-08-12 | Inst De Pesquisa Em Saude Anim | Abamectin plus ivermectin combination for use as endectocide in cattle |
-
2004
- 2004-10-15 TR TR2006/01608T patent/TR200601608T1/en unknown
- 2004-10-15 BR BRPI0415366-9A patent/BRPI0415366A/en not_active Application Discontinuation
- 2004-10-15 CN CN2004800305841A patent/CN1867341B/en not_active Expired - Lifetime
- 2004-10-15 WO PCT/EP2004/052554 patent/WO2005037294A1/en active Application Filing
- 2004-10-15 AU AU2004281551A patent/AU2004281551B2/en not_active Expired
- 2004-10-15 NZ NZ546340A patent/NZ546340A/en unknown
-
2006
- 2006-05-16 ZA ZA200603931A patent/ZA200603931B/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU2004281551A1 (en) | 2005-04-28 |
CN1867341B (en) | 2010-06-16 |
TR200601608T1 (en) | 2006-12-21 |
CN1867341A (en) | 2006-11-22 |
AU2004281551B2 (en) | 2009-10-29 |
NZ546340A (en) | 2009-08-28 |
WO2005037294A1 (en) | 2005-04-28 |
ZA200603931B (en) | 2007-09-26 |
WO2005037294A8 (en) | 2005-07-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0519195A2 (en) | oral care composition, and method for preventing or treating dental caries in a human or animal subject | |
DK1294383T3 (en) | Oral compositions comprising antimicrobial agents to prevent systemic diseases | |
BR9911795A (en) | Formulations to control human lice | |
BRPI0804518A2 (en) | method of controlling a dog population | |
BR0201719A (en) | Pharmaceutical compositions pleasant to the taste for pets | |
UY26269A1 (en) | COMMON SALT AND MOXIFLOXACIN FORMULATION | |
CU23260B7 (en) | MOXIFLOXACINE PHARMACEUTICAL PREPARATION | |
BR112012015961A2 (en) | compositions including pyruvate for pets and methods of use thereof | |
ATE392889T1 (en) | ORAL ANTIMICROBIAL PHARMACEUTICAL COMPOSITIONS | |
WO2009055799A3 (en) | Compositions and methods for treatment of diseases of the foot of an animal | |
CO5221025A1 (en) | 4-TRIFLUOROMETIL-3-OXAZOLILPIRIDINAS, PROCEDURE FOR THEIR PREPARATION, AGENTS THAT CONTAIN THEM AND THEIR USE AS AN AGENT FOR THE FIGHT AGAINST DANIN ORGANISMS | |
BRPI0415366A (en) | long-acting composition to control parasites internal and external to animals, and use of the same | |
ATE272397T1 (en) | SELECTIVE ANTIBACTERIAL COMPOSITIONS | |
BR0203388A (en) | Endoparasiticide Gel Composition | |
BR0113062A (en) | Heterocyclylalkylazole derivatives and their use as a parasite control agent | |
BR0312156A (en) | Insect repellents | |
BRPI0407667A (en) | estradiol metabolites for the treatment of pulmonary hypertension | |
BRPI0413025A8 (en) | organic compounds | |
BRPI0418764A (en) | use of spinosine or a physiologically acceptable derivative or salt thereof | |
BR0209430A (en) | Heterocyclic Compounds | |
BR0309515A (en) | Conductive wound dressings and methods of use | |
BRPI0405662A (en) | Turobuterol containing plasters | |
CL2004000146A1 (en) | MONOSACARID DERIVATIVES OF AVERMECTIN REPLACED IN 4 'OR 4 ", COMPOSITION CONTAINING IT, USEFUL TO CONTROL PESTS. | |
BRPI0603258A (en) | skin compositions | |
DOP2011000030A (en) | COMBINATION COCCIDICIDE FOR VETERINARY USE |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according art. 34 industrial property law | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law | ||
B07E | Notice of approval relating to section 229 industrial property law |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B07A | Technical examination (opinion): publication of technical examination (opinion) | ||
B09B | Decision: refusal | ||
B12B | Appeal: appeal against refusal |